Skip to content
VuFind
Book Bag:
0
items
(Full)
Institutional Login
Language
English
Deutsch
All Fields
Title
Author
Subject
ISBN/ISSN
K10+-PPN
OCLC Number
Find
Advanced
Start
Cite this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Export to RDF
Export to BibTeX
Export to RIS
Save to List
Permanent link
Saved in:
Bibliographic Details
Main Author:
Weisel, Katja
(Author)
Online Access:
Description
Staff View
Description
Description not available.
Similar Items
Analysis of renal impairment in MM-003: a phase III study of pomalidomide + low-dose dexamethasone versus high-dose dexamethasone in refractory or relapsed and refractory multiple myeloma
by: Weisel, Katja, et al.
Published: (2016)
Health-related quality of life of carfilzomib- and daratumumab-based therapies in patients with relapsed/refractory multiple myeloma, based on German benefit assessment data
by: Weisel, Katja, et al.
Published: (2020)
Addition of cyclophosphamide on insufficient response to pomalidomide and dexamethasone: results of the phase II PERSPECTIVE multiple myeloma trial
by: Weisel, Katja, et al.
Published: (2019)
MCT1 as molecularly validated predictive marker for lenalidomide-maintenance therapy in multiple myeloma
by: Stroh, Jacob, et al.
Published: (2019)
Deepening responses associated with improved progression-free survival with ixazomib versus placebo as posttransplant maintenance in multiple myeloma
by: Goldschmidt, Hartmut, et al.
Published: (2020)
